Testing effectiveness (Phase 2)Study completedNCT02824133
What this trial is testing
Treatment With AZD4547 for Recurrent Malignant Glioma Expressing FGFR-TACC Gene Fusion"
Who this might be right for
Recurrent IDHwt Gliomas With FGFR3-TACC3 FusionRecurrent IDHwt Gliomas With FGFR1-TACC1 Fusion
Assistance Publique - Hôpitaux de Paris 14